Syncona rakes in the cash as Bracco buys Blue Earth for $450mImaging company Bracco is to buy Blue Earth Diagnostics for $450 million, netting £337 million for its owner Syncona, Share XSyncona rakes in the cash as Bracco buys Blue Earth for $450mhttps://pharmaphorum.com/news/syncona-rakes-in-the-cash-as-bracco-buys-blue-earth-for-450m/
Syncona joins Gyroscope, Orbit to create eye gene therapy playerUK biotech Gyroscope Therapeutics is to merge with Orbit Biomedical of the US to create a specialist in Share XSyncona joins Gyroscope, Orbit to create eye gene therapy playerhttps://pharmaphorum.com/news/syncona-gyroscope-orbit-eye-gene-therapy/
